Challenges of Cell Therapy for Lung Diseases and Critical Illnesses
Author:
Publisher
Springer International Publishing
Link
http://link.springer.com/content/pdf/10.1007/978-3-319-16232-4_6
Reference155 articles.
1. Aguilar S, Scotton CJ, McNulty K et al (2009) Bone marrow stem cells expressing keratinocyte growth factor via an inducible lentivirus protects against bleomycin-induced pulmonary fibrosis. PLoS One 4:e8013
2. Aliotta JM, Lee D, Puente N, Faradyan S, Sears E, Amaral A, Goldberg L, Dooner MS, Pereira M, Quesenberry PJ (2012) Progenitor/stem cell fate determination: interactive dynamics of cell cycle and microvesicles. Stem Cells Dev 21(10):1627–1638
3. Antunes MA, Laffey JG, Pelosi P, Rocco PR (2014) Mesenchymal stem cell trials for pulmonary diseases. J Cell Biochem. doi: 10.1002/jcb.24783
4. Baber SR, Deng W, Master RG, Bunnell BA, Taylor BK, Murthy SN, Hyman AL, Kadowitz PJ (2007) Intratracheal mesenchymal stem cell administration attenuates monocrotaline-induced pulmonary hypertension and endothelial dysfunction. Am J Physiol Heart Circ Physiol 292:H1120–H1128
5. Baer PC (2011) Adipose-derived stem cells and their potential to differentiate into the epithelial lineage. Stem Cells Dev 20(10):1805–1816
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3